妊娠早期将甲巯咪唑换为碘化钾后甲状腺激素升高的Graves病患者特征
研究纳入2005年1月1日至2018年3月31日期间妊娠早期将甲巯咪唑(MMI)换为无机碘控制甲亢的240例Graves病(GD)女性患者。133例(55.4%)在妊娠期间完全停药,107例(44.6%)分娩时仍在用药,其中57例单用碘化钾、50例使用抗甲状腺药物联合或不联合碘化钾。107例中22例单用碘化钾难以控制母体甲状腺毒症且需要比受孕时更高剂量的MMI(恶化组)。多因素分析显示,换药时TRAb值是预测继续使用甲状腺抑制药物的唯一因素,但无参数可预测恶化组。
要点
- 妊娠早期MMI换为碘化钾后,部分GD患者可逃逸碘的抗甲状腺作用,需警惕甲状腺激素升高。
- 换药时TRAb值是预测继续使用甲状腺抑制药物的唯一因素,但未能预测恶化组。
- 单用碘化钾控制不佳时可能需要比受孕时更高剂量的MMI。
核心结论
- 必须牢记一定比例的GD患者会逃逸碘的抗甲状腺作用,妊娠患者换用碘化钾后需要仔细随访。
研究设计与样本
- 研究纳入2005年1月1日至2018年3月31日期间妊娠早期将MMI换为无机碘控制甲亢的240例GD女性患者。
主要发现
- 133例(55.4%)GD患者在妊娠期间完全停药,其余107例(44.6%)分娩时仍在用药:57例单用碘化钾,50例使用抗甲状腺药物联合或不联合碘化钾。
- 107例患者中22例单用碘化钾难以控制母体甲状腺毒症,需要比受孕时更高剂量的MMI(恶化组)。
- 多因素分析显示,换药时TRAb值是预测继续使用甲状腺抑制药物的唯一因素,但无参数可预测恶化组。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: The clinical course of Graves' disease (GD) in women who switched from methimazole (MMI) to potassium iodide (KI) during the first trimester of pregnancy has never been reported in detail. Objective: To investigate the characteristics of GD patients whose thyroid hormone levels increase after substituting KI for MMI. Patients: Two hundred forty women with GD who had been treated with MMI and switched from MMI to inorganic iodide to control hyperthyroidism during the first trimester between January 1, 2005, and March 31, 2018. Results: In 133 (55.4%) of the GD patients, medication was completely tapered during pregnancy, and the other 107 (44.6%) GD patients were taking medication at delivery: 57 were taking KI alone and 50 were taking an antithyroid drug with or without KI. It was difficult to control the maternal thyrotoxicosis of 22 of the 107 patients with KI alone, and a higher dose of MMI compared with the dose at the time of conception was required (worsened group). Multivariate analysis revealed that the TRAb value at the time of switch from MMI to KI was the only factor that predicted continuation of the thyroid suppression medication, but none of the parameters was a predictor of the worsened group. Conclusions: It must be kept in mind that a certain proportion of GD patients escape from the antithyroid effect of iodide and that careful follow-up is necessary after switching a pregnant patient's medication to KI.
引用
- Yoshihara A, Noh JY, Watanabe N, et al. Characteristics of Patients with Graves' Disease Whose Thyroid Hormone Levels Increase After Substituting Potassium Iodide for Methimazole in the First Trimester of Pregnancy. Thyroid. 2020. PMID: 31928169. doi:10.1089/thy.2019.0392
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。